Brian Piekos - 01 Feb 2024 Form 4 Insider Report for Elicio Therapeutics, Inc. (ELTX)

Role
Chief Financial Officer
Signature
/s/Brian Piekos
Issuer symbol
ELTX
Transactions as of
01 Feb 2024
Transactions value $
$0
Form type
4
Date filed
05 Feb 2024, 06:01
Previous filing
05 Jun 2023
Next filing
11 Sep 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ELTX Stock Option (right to buy) Award $0 +43.2K $0.00 43.2K 01 Feb 2024 Common Stock 43.2K $4.50 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Twenty five percent (25%) of the stock options vest on February 1, 2025, the one-year anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.